Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 810.09M |
| Enterprise value | 506.50M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 5.20 |
| Price/book (mrq) | 4.61 |
| Enterprise value/revenue | 3.26 |
| Enterprise value/EBITDA | -20.26 |
Trading information
Stock price history
| Beta (5Y monthly) | 3.62 |
| 52-week change 3 | -57.42% |
| S&P500 52-week change 3 | 24.55% |
| 52-week high 3 | 29.90 |
| 52-week low 3 | 5.41 |
| 50-day moving average 3 | 7.24 |
| 200-day moving average 3 | 14.48 |
Share statistics
| Avg vol (3-month) 3 | 1.89M |
| Avg vol (10-day) 3 | 2.24M |
| Shares outstanding 5 | 91.85M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 68.95M |
| % held by insiders 1 | 9.04% |
| % held by institutions 1 | 87.70% |
| Shares short (14 Nov 2021) 4 | 8.89M |
| Short ratio (14 Nov 2021) 4 | 5.33 |
| Short % of float (14 Nov 2021) 4 | 17.09% |
| Short % of shares outstanding (14 Nov 2021) 4 | 9.67% |
| Shares short (prior month 14 Oct 2021) 4 | 8.15M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2020 |
| Most-recent quarter (mrq) | 29 Sept 2021 |
Profitability
| Profit margin | -21.79% |
| Operating margin (ttm) | -21.23% |
Management effectiveness
| Return on assets (ttm) | -5.47% |
| Return on equity (ttm) | -18.60% |
Income statement
| Revenue (ttm) | 155.27M |
| Revenue per share (ttm) | 1.70 |
| Quarterly revenue growth (yoy) | 8,843.20% |
| Gross profit (ttm) | -57.35M |
| EBITDA | -27.05M |
| Net income avi to common (ttm) | -33.83M |
| Diluted EPS (ttm) | -0.37 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 347.39M |
| Total cash per share (mrq) | 3.78 |
| Total debt (mrq) | 43.79M |
| Total debt/equity (mrq) | 24.92 |
| Current ratio (mrq) | 3.79 |
| Book value per share (mrq) | 1.91 |
Cash flow statement
| Operating cash flow (ttm) | 40.62M |
| Levered free cash flow (ttm) | 29.95M |
© 2021 Yahoo. All rights reserved.
